Search Results - "Elkord, E."

Refine Results
  1. 1

    In‐vitro effect of pembrolizumab on different T regulatory cell subsets by Toor, S. M., Syed Khaja, A. S., Alkurd, I., Elkord, E.

    Published in Clinical and experimental immunology (01-02-2018)
    “…Summary Programmed death‐1 (PD‐1) and interactions with PD‐ligand 1 (PD‐L1) play critical roles in the tumour evasion of immune responses through different…”
    Get full text
    Journal Article
  2. 2

    Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia by Daayana, S, Elkord, E, Winters, U, Pawlita, M, Roden, R, Stern, P L, Kitchener, H C

    Published in British journal of cancer (30-03-2010)
    “…Background: Vulval intraepithelial neoplasia (VIN) is a premalignant condition, which is frequently associated with type HPV16 infection, and multifocal…”
    Get full text
    Journal Article
  3. 3

    Effect of pembrolizumab on CD4+CD25+, CD4+LAP+ and CD4+TIM‐3+ T cell subsets by Toor, S. M., Sasidharan Nair, V., Pfister, G., Elkord, E.

    Published in Clinical and experimental immunology (01-06-2019)
    “…Summary Tumor immune evasion involves the expansion of avidly proliferating immunosuppressive cells and inhibition of effector T cell proliferation. Immune…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Immunology and immunotherapy approaches for prostate cancer by Elkord, E

    Published in Prostate cancer and prostatic diseases (01-09-2007)
    “…Several mechanisms that impair the immune response to promote tumour progression are reported. These mechanisms aim to reduce the ability of antigen-presenting…”
    Get full text
    Journal Article
  6. 6

    Novel therapeutic strategies by regulatory T cells in allergy by Elkord, E

    Published in Chemical immunology and allergy (2008)
    “…Natural CD4+CD25+FoxP3+ regulatory T cells (Treg) actively suppress physiological and pathological responses, therefore playing a critical role in controlling…”
    Get more information
    Journal Article
  7. 7

    Novel IFNγ ELISPOT Assay for Detection of Functional Carcinoembryonic Antigen‐Specific Chimeric Antigen Receptor‐Redirected T Cells by Elkord, E., Burt, D. J.

    Published in Scandinavian journal of immunology (01-10-2011)
    “…We here describe the development of a novel ELISPOT assay for the detection and enumeration of IFNγ‐secreting functional chimeric antigen receptor…”
    Get full text
    Journal Article
  8. 8

    5T4 oncofetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotype by Castro, F V, McGinn, O J, Krishnan, S, Marinov, G, Li, J, Rutkowski, A J, Elkord, E, Burt, D J, Holland, M, Vaghjiani, R, Gallego, A, Saha, V, Stern, P L

    Published in Leukemia (01-07-2012)
    “…Although the overall prognosis in childhood acute lymphoblastic leukemia (ALL) is good, outcome after relapse is poor. Recurrence is frequently characterized…”
    Get full text
    Journal Article
  9. 9

    Frequency of human T regulatory cells in peripheral blood is significantly reduced by cryopreservation by Elkord, Eyad

    Published in Journal of immunological methods (15-08-2009)
    “…Cryopreservation of peripheral blood mononuclear cells (PBMC) is essential for many clinical and research assays. Some studies reported consistent changes in…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells by Elkord, Eyad, Williams, Paul E., Kynaston, Howard, Rowbottom, Anthony W.

    Published in Immunology (01-02-2005)
    “…Summary There is growing interest in the in vitro generation of dendritic cells (DC) from peripheral blood monocytes, but the effect of the method chosen to…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Correlation between CD8 super(+) T cells specific for prostate-specific antigen and level of disease in patients with prostate cancer by Elkord, E, Rowbottom, A W, Kynaston, H, Williams, P E

    Published in Clinical Immunology (01-07-2006)
    “…Modest work has been performed to improve the sensitivity of residual disease detection or investigate the contribution that the immune system makes in…”
    Get full text
    Journal Article
  18. 18

    Correlation between CD8+ T cells specific for prostate-specific antigen and level of disease in patients with prostate cancer by Elkord, Eyad, Rowbottom, Anthony W., Kynaston, Howard, Williams, Paul E.

    Published in Clinical immunology (Orlando, Fla.) (01-07-2006)
    “…Modest work has been performed to improve the sensitivity of residual disease detection or investigate the contribution that the immune system makes in…”
    Get full text
    Journal Article
  19. 19

    CD4 super(+) T-cell recognition of human 5T4 oncofoetal antigen: implications for initial depletion of CD25 super(+) T cells by Elkord, Eyad, Burt, Deborah J, Drijfhout, Jan W, Hawkins, Robert E, Stern, Peter L

    Published in Cancer Immunology, Immunotherapy (01-06-2008)
    “…Background: The human 5T4 (h5T4) oncofoetal antigen is expressed by a wide variety of human carcinomas including colorectal, ovarian, gastric and renal, but…”
    Get full text
    Journal Article
  20. 20

    Differential CTLs specific for prostate-specific antigen in healthy donors and patients with prostate cancer by Elkord, Eyad, Williams, Paul E., Kynaston, Howard, Rowbottom, Anthony W.

    Published in International immunology (01-10-2005)
    “…Induction of CTL responses specific for prostate-specific antigen (PSA)-derived peptides in healthy individuals and patients with prostate cancer (PC) was…”
    Get full text
    Journal Article